Article

A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma

2020-10-21

Abstract excerpt

<h4>Purpose</h4> Osteosarcoma is a rare but aggressive bone cancer that occurs primarily in children. Like other rare cancers, treatment advances for osteosarcoma have stagnated, with little improvement in survival for the past several decades. Developing new treatments has been hampered by extensive genomic heterogeneity and limited access to patient samples to study the biology of this complex disease. <h4>Expe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 799d6e88-5b4f-59d5-8962-c9639544b044
DOI: 10.1101/2020.10.19.346387

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcomaDOI 10.1101/2020.10.19.346387Read

Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacitiesSemantic proximity Read

Patient Derived Xenografts for Genome-Driven Therapy of OsteosarcomaSemantic proximity Read

Relationship between Osteosarcoma Therapy and Tumorigenesis, Metastasis, Immune Evasion, and ChemoresistanceSemantic proximity Read

Advances in Target Therapy Research in OsteosarcomaSemantic proximity Read

Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted ApproachSemantic proximity Read

Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft modelsSemantic proximity Read

Patient-derived osteosarcoma tumoroid model reveals functional phenotypic diversity with implications for drug responses.Semantic proximity Read

Novel insights and therapeutic interventions for pediatric osteosarcoma.Semantic proximity Read

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatmentSemantic proximity Read

A Self-Assembling Immune-Featured Osteosarcoma Patient/PDX Derived Organoid Model and Biobank for Personalized Immune TherapySemantic proximity Read

Integrative Single-cell and Spatial Transcriptomic Analysis of Osteosarcoma Reveals Conserved and Distinct Ecosystems Across Sites and SpeciesSemantic proximity Read

Collateral sensitivities with predictive signatures emerge in a novel model of evolved chemoresistance in osteosarcomaSemantic proximity Read